Meanwhile, data from the TCGA database showed that the high expression of IGF2BP1 was associated with inferior survival in patients with NSCLC, but the expressions of IGF2BP2 or IGF2BP3 were not related to overall survival (Figure S3A). Here, IGF2BP3 is linked to non-small cell lung carcinoma.